• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麦普替林用于成年抑郁症患者。重复静脉注射和口服给药后临床疗效与血清浓度关系的研究。

Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.

作者信息

Fischbach R

出版信息

Arzneimittelforschung. 1979;29(2):352-5.

PMID:36112
Abstract

Maprotiline was administered initially i.v. and then p.o. to 15 adult depressive in-patients daily for three weeks in various dosages. Serum concentrations were monitored in an attempt to find a correlation to clinical response. The steady-state serum concentration attained is independent of the dosage administered. The results suggest that patients who maintain a high serum concentration will show a better therapeutic response to the drug. In 11 out of 14 patients evaluated after three weeks of daily maprotiline therapy the clinical response could be described as excellent or very good. The drug was well tolerated when given by either route.

摘要

对15名成年抑郁住院患者初始静脉注射随后口服不同剂量的麦普替林,为期三周,每日给药。监测血清浓度以试图找出其与临床反应的相关性。达到的稳态血清浓度与给药剂量无关。结果表明,维持高血清浓度的患者对该药物将表现出更好的治疗反应。在每日麦普替林治疗三周后评估的14名患者中,有11名患者的临床反应可描述为极佳或非常好。该药物通过任何一种途径给药时耐受性良好。

相似文献

1
Maprotiline in adult depressed patients. A study of the relation between clinical efficacy and serum concentrations after repeated intravenous and peroral administration.麦普替林用于成年抑郁症患者。重复静脉注射和口服给药后临床疗效与血清浓度关系的研究。
Arzneimittelforschung. 1979;29(2):352-5.
2
Efficacy, side-effects, plasma and blood levels of maprotiline (Ludiomil).
J Int Med Res. 1977;5 Suppl 4:101-11.
3
Maprotiline (Ludiomil) in depression: a report of a monitored release study in general practice.马普替林(路滴美)治疗抑郁症:一项全科医疗中缓释制剂的监测研究报告
J Int Med Res. 1977;5 Suppl 4:112-5.
4
[Use of ludiomil in intravenous perfusions in the treatment of depressive states].[路滴美在静脉滴注治疗抑郁状态中的应用]
Ann Med Psychol (Paris). 1975 Nov;2(4):748-56.
5
Multicenter evaluation of maprotiline hydrochloride for treatment of depression.盐酸马普替林治疗抑郁症的多中心评估
Clin Ther. 1984;6(2):155-62.
6
[Blood concentrations of maprotiline in depressive patients].[抑郁症患者体内麦普替林的血药浓度]
Encephale. 1988 Jul-Aug;14(4):299-305.
7
Maprotiline (Ludiomil) in depression: a multicentre assessment of onset of action, efficacy and tolerability.
J Int Med Res. 1977;5 Suppl 4:116-21.
8
[Double blind study on maprotiline, an example of a multidimensional psychopharmacologic experiment (author's transl)].
Pharmakopsychiatr Neuropsychopharmakol. 1978 Mar;11(2):63-7. doi: 10.1055/s-0028-1094563.
9
Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response.
Postgrad Med J. 1977;53 Suppl 4:155-9.
10
A comparison of high and low dosage regimes of maprotiline (Ludiomil).
J Int Med Res. 1977;5 Suppl 4:3-10.